💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

BRIEF-Janssen Biotech says collaboration with Canadian Biotechs Novera, Engene Inc

Published 2015-10-14, 08:26 a/m
© Reuters.  BRIEF-Janssen Biotech says collaboration with Canadian Biotechs Novera, Engene Inc
JNJ
-

Oct 14 (Reuters) - Janssen Biotech Inc:
* Johnson & Johnson (N:JNJ) Innovation announces collaborations with Canadian Biotechs Novera Therapeutics, Inc. and Engene, Inc
* Janssen biotech inc - agreements seek new treatments for hematological
malignancies and inflammatory bowel disease
* Janssen biotech - agreement with novera is collaboration that includes
Ontario institute for cancer research together with university health network
* Janssen biotech - agreement will allow janssen to accelerate the development
of promising small molecule drug candidates for hematological cancers
* Janssen biotech - separate agreement with engene allows for development and
commercialization of new therapies for inflammatory bowel disease
* Janssen biotech - engene and janssen will jointly develop eg-12 through to
clinical proof of mechanism in patients with ibd
* Janssen biotech - upon exercise of option, janssen will take further clinical development and commercialization of eg-12 for all indications worldwide

* Source text for Eikon ID:nCNWpRhPwa

* Further company coverage JNJ.N

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.